These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16276122)

  • 1. Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes.
    Zhang S; Rodriguez R; Scholz PM; Weiss HR
    Pharmacology; 2006; 76(2):53-60. PubMed ID: 16276122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
    J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
    Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
    Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
    Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
    Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
    Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
    Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
    Weiss HR; Rodriguez E; Tse J; Scholz PM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.
    Ziolo MT; Lewandowski SJ; Smith JM; Romano FD; Wahler GM
    Br J Pharmacol; 2003 Mar; 138(5):986-94. PubMed ID: 12642401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
    Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
    Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing cyclic GMP exerts similar positive functional effects on cardiac myocytes regardless of initial level.
    Yan L; Huang MW; Scholz PM; Weiss HR
    Pharmacology; 2000 Jul; 61(1):51-6. PubMed ID: 10895081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal muscarinic activity does not impede beta-adrenergic activation in rabbit hearts in controls or thyroxine-induced cardiac hypertrophy.
    Naim KL; Rabindranauth P; Scholz PM; Tse J; Weiss HR
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):405-11. PubMed ID: 9335397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of triiodothyronine pretreatment on beta-adrenergic responses in stunned cardiac myocytes.
    Tse J; Gandhi A; Yan L; He YQ; Weiss HR
    J Cardiothorac Vasc Anesth; 2003 Aug; 17(4):486-90. PubMed ID: 12968237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes.
    Sandirasegarane L; Diamond J
    Pharmacology; 2004 Jan; 70(1):46-56. PubMed ID: 14646356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.